Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway
The Journal of Pathology · 2024
DOI: 10.1002/path.6219 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pathology, 2024. Verfasst von Karim H Saba und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Division of Clinical Genetics, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Osteosarcoma, Bone Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, Barncancerfonden, Cancerfonden.
Abstract (Originalsprache)
TP53 is the most frequently mutated gene in human cancer. This gene shows not only loss‐of‐function mutations but also recurrent missense mutations with gain‐of‐function activity. We have studied the primary bone malignancy osteosarcoma, which harbours one of the most rearranged genomes of all cancers. This is odd since it primarily affects children and adolescents who have not lived the long life thought necessary to accumulate massive numbers of mutations. In osteosarcoma, TP53 is often disrupted by structural variants. Here, we show through combined whole‐genome and transcriptome analyses of 148 osteosarcomas that TP53 structural variants commonly result in loss of coding parts of the gene while simultaneously preserving and relocating the promoter region. The transferred TP53 promoter region is fused to genes previously implicated in cancer development. Paradoxically, these erroneously upregulated genes are significantly associated with the TP53 signalling pathway itself. This suggests that while the classical tumour suppressor activities of TP53 are lost, certain parts of the TP53 signalling pathway that are necessary for cancer cell survival and proliferation are retained. In line with this, our data suggest that transposition of the TP53 promoter is an early event that allows for a new normal state of genome‐wide rearrangements in osteosarcoma. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Division of Clinical Genetics, Lund University, Lund, Sweden.
- Bone Tumour Reference Centre at the Institute of Pathology, University Hospital and University of Basel, Basel, Switzerland.
- Faculty of Informatics and Information Technologies, Slovak University of Technology, Bratislava, Slovakia.
- European Research Institute for the Biology of Ageing, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
- Department of Clinical Genetics and Pathology, Laboratory Medicine, Medical Services, Skåne University Hospital, Lund, Sweden.
- Department of Musculoskeletal Pathology, Royal Orthopaedic Hospital, Birmingham, UK.
ORCID-Profile: Karim H Saba, Karolin H Nord
Förderung
- Swiss National Science Foundation
- Barncancerfonden
- Cancerfonden
- Royal Swedish Academy of Sciences
- Vetenskapsrådet
- Lunds Universitet
- Åke Wiberg Stiftelse
- Kungliga Fysiografiska Sällskapet i Lund
Zitieren
APA
Saba, K. H., Difilippo, V., Kovac, M., Cornmark, L., Magnusson, L., Nilsson, J., van den Bos, H., Spierings, D. C., Bidgoli, M., Jonson, T., Sumathi, V. P., Brosjö, O., Staaf, J., Foijer, F., Styring, E., Nathrath, M., Baumhoer, D., & Nord, K. H. (2024). Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway. The Journal of Pathology. https://doi.org/10.1002/path.6219
Vancouver
Saba KH, Difilippo V, Kovac M, Cornmark L, Magnusson L, Nilsson J, et al. Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway. The Journal of Pathology. 2024. doi:10.1002/path.6219
BibTeX
@article{Saba2024,
author = {Saba, Karim H and Difilippo, Valeria and Kovac, Michal and Cornmark, Louise and Magnusson, Linda and Nilsson, Jenny and van den Bos, Hilda and Spierings, Diana Cj and Bidgoli, Mahtab and Jonson, Tord and Sumathi, Vaiyapuri P and Brosjö, Otte and Staaf, Johan and Foijer, Floris and Styring, Emelie and Nathrath, Michaela and Baumhoer, Daniel and Nord, Karolin H},
title = {Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway},
journal = {The Journal of Pathology},
year = {2024},
doi = {10.1002/path.6219}
}
EUVIMED